Citation Impact
Citing Papers
BACE1 inhibition reduces endogenous Abeta and alters APP processing in wild‐type mice2
2006
Plasma β-amyloid in Alzheimer’s disease and vascular disease
2016 StandoutNobel
The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
2011 Standout
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
2010
Blood protein predictors of brain amyloid for enrichment in clinical trials?
2015 StandoutNobel
Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives
2010
Alzheimer's disease
2016 Standout
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Concentration-Dependent Modulation of Amyloid-β in Vivo and in Vitro Using the γ-Secretase Inhibitor, LY-450139
2006
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
2011 Standout
Dynamics of Aβ Turnover and Deposition in Different β-Amyloid Precursor Protein Transgenic Mouse Models Following γ-Secretase Inhibition
2008
Down syndrome
2020 Standout
Development of Beta-Amyloid-induced Neurodegeneration in Alzheimer's Disease and Novel Neuroprotective Strategies
2005
The Diagnosis of Mild Cognitive Impairment due to Alzheimer’s Disease: Recommendations from the National Institute on Aging-Alzheimer’s Association Workgroups on Diagnostic Guidelines for Alzheimer’s Disease
2013 Standout
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
2011 Standout
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
2011 Standout
Optimal design of clinical trials for drugs designed to slow the course of Alzheimer's disease
2006
Plasma tau in Alzheimer disease
2016 StandoutNobel
Development and evaluation of a multiplexed mass spectrometry based assay for measuring candidate peptide biomarkers in Alzheimer's Disease Neuroimaging Initiative (ADNI) CSF
2015 StandoutNobel
Amyloid precursor protein–mediated endocytic pathway disruption induces axonal dysfunction and neurodegeneration
2016
Works of Bowei Wang being referenced
Reductions in β-amyloid concentrations in vivo by the γ-secretase inhibitors BMS-289948 and BMS-299897
2005